The European Union has taken significant steps to update and strengthen the regulatory framework for medical devices and in vitro diagnostic medical devices. This revision was necessary to keep pace with rapid advancements in technology and medical science observed over the past two decades. These changes signify a major overhaul...
Healthcare in Europe by 2044
As Europe navigates these myriad challenges, the need for a visionary and unified approach to healthcare is becoming increasingly apparent. The continent's diverse healthcare systems, while rich in their unique adaptations, also contribute to fragmentation and inefficiency at a broader level. This divergence not only complicates policy coordination and resource...
ASCA 2024
Key Takeaways from ASCA 2024 The insights from the ASCA 2024 annual meeting underscore a significant shift towards more efficient, cost-effective, and technologically advanced outpatient surgical care. MedTech companies, especially those with strategic products and services tailored for ASCs, stand to benefit greatly from these trends. Companies like Stryker are...